Molecular and functional analysis ofSLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency
- 30 August 2004
- journal article
- case report
- Published by Hindawi Limited in Human Mutation
- Vol. 24 (4) , 312-320
- https://doi.org/10.1002/humu.20085
Abstract
The enzyme carnitine‐acylcarnitine translocase (CACT) is involved in the transport of long‐chain fatty acids into mitochondria. CACT deficiency is a life‐threatening, recessively inherited disorder of lipid β‐oxidation which manifests in early infancy with hypoketotic hypoglycemia, cardiomyopathy, liver failure, and muscle weakness. We report here the clinical, biochemical, and molecular features of six CACT‐deficient patients from Italy, Spain, and North America who exhibited significant clinical heterogeneity. In five patients (Patients 1, 2, 4, 5, and 6) the disease manifested in the neonatal period, while the remaining patient (Patient 3), the younger sibling of an infant who had died with clinical suspicion of fatty acid oxidation defect, has been treated since birth and was clinically asymptomatic at 4.5 years of age. Patients 1 and 4 were deceased within 6 months from the onset of this study, while the remaining four are still alive at 8, 4.5, 3.5, and 2 years, respectively. Sequence analysis of the CACT gene (SLC25A20) disclosed five novel mutations and three previously reported mutations. Three patients were homozygous for the identified mutations. Two of the novel mutations (c.718+1G>C and c.843+4_843+50del) altered the donor splice site of introns 7 and 8, respectively. The 47‐nt deletion in intron 8 caused both skipping of exon 8 only and skipping of exons 6–8. Four mutations {[c.159dupT;c.163delA] ([p.Gly54Trp;p.Thr55Ala]) c.397C>T (p.Arg133Trp), c.691G>C (p.Asp231His), and c.842C>T (p.Ala281Val)} resulted in amino acid substitutions affecting evolutionarily conserved regions of the protein. Interestingly, one of these exonic mutations (p.Ala281Val) was associated with a splicing defect also characterized by skipping of exons 6–8. The deleterious effect of the p.Arg133Trp substitution was demonstrated by measuring CACT activity upon expression of the normal and the mutant protein in E. coli and functional reconstitution into liposomes. Combined analysis of clinical, biochemical, and molecular data failed to indicate a correlation between the phenotype and the genotype. Hum Mutat 24:312–320, 2004.Keywords
This publication has 31 references indexed in Scilit:
- A Novel Mitochondrial Carnitine-acylcarnitine Translocase Induced by Partial Hepatectomy and FastingJournal of Biological Chemistry, 2003
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Aberrant mRNA Splicing Associated with Coding Region Mutations in Children with Carnitine-Acylcarnitine Translocase DeficiencyMolecular Genetics and Metabolism, 2001
- Functional Analysis of Mutant Human Carnitine Acylcarnitine Translocases in YeastBiochemical and Biophysical Research Communications, 2001
- The Structure and Organization of the Human Carnitine/Acylcarnitine Translocase (CACT) GeneBiochemical and Biophysical Research Communications, 1998
- Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndromeNature Genetics, 1997
- The ARG11 Gene of Saccharomyces cerevisiae Encodes a Mitochondrial Integral Membrane Protein Required for Arginine BiosynthesisPublished by Elsevier ,1996
- Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patientsNature Genetics, 1993
- Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.Journal of Clinical Investigation, 1993
- The mechanism of fatty acid uptake by heart mitochondria: An acylcarnitine‐carnitine exchangeFEBS Letters, 1975